Insider trade

Alamar Biosciences (ALMR)10% owner bought ~$4M

Illumina Innovation Fund II GP, 10% owner at Alamar Biosciences, bought ~$4M of Alamar Biosciences shares.

~$4M
Approx. value · 235K sh @ $17.00
507K
Holds after · shares reported
Traded
Apr 20, 2026
Filed
Apr 21, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Apr 20, 2026 · this disclosureInsider10% owner purchased ~$4M of ALMR shares in the open market

What came next

  1. Apr 20, 2026Company filing · Form 8-K · Bylaws or charter, Other newsChanged its bylaws, charter or fiscal year, and reported other company news
  2. Apr 20, 2026InsiderDirector purchased ~$4M of ALMR shares in the open market
  3. May 8, 2026Company filing · Form 8-K · ResultsReported its results
  4. Aug 10, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Alamar Biosciences

For Alamar Biosciences, OQRO holds 2 fund holdings reports (13F) and 3 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ALMR page.

How this filing works

Other disclosures at Alamar Biosciences

Everything OQRO holds on this company is on its ALMR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data